MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
- PMID: 22484425
- DOI: 10.1038/onc.2012.106
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
Abstract
Neuroblastoma is an embryonal tumor with a heterogeneous clinical course. The tumor is presumed to be derived from the neural crest, but the cells of origin remain to be determined. To date, few recurrent genetic changes contributing to neuroblastoma formation, such as amplification of the MYCN oncogene and activating mutations of the ALK oncogene, have been identified. The possibility to model neuroblastoma in mice allows investigation of the cell of origin hypothesis in further detail. Here we present the evidence that murine neural crest progenitor cells can give rise to neuroblastoma upon transformation with MYCN or ALK(F1174L). For this purpose we used JoMa1, a multipotent neural crest progenitor cell line, which is kept in a viable and undifferentiated state by a tamoxifen-activated c-Myc transgene (c-MycER(T)). Expression of MYCN or ALK(F1174L), one of the oncogenic ALK variants identified in primary neuroblastomas, enabled these cells to grow independently of c-MycER(T) activity in vitro and caused formation of neuroblastoma-like tumors in vivo in contrast to parental JoMa1 cells and JoMa1 cells-expressing TrkA or GFP. Tumorigenicity was enhanced upon serial transplantation of tumor-derived cells, and tumor cells remained susceptible to the MYC-inhibitor, NBT-272, indicating that cell growth depended on functional MYCN. Our findings support neural crest progenitor cells as the precursor cells of neuroblastoma, and indicate that neuroblastomas arise as their malignant progeny.
Similar articles
-
Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.Oncogene. 2012 Dec 13;31(50):5193-200. doi: 10.1038/onc.2012.12. Epub 2012 Jan 30. Oncogene. 2012. PMID: 22286764
-
Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.Oncotarget. 2014 Jun 30;5(12):4452-66. doi: 10.18632/oncotarget.2036. Oncotarget. 2014. PMID: 24947326 Free PMC article.
-
Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.Cell Death Dis. 2017 Dec 13;8(12):3208. doi: 10.1038/s41419-017-0004-9. Cell Death Dis. 2017. PMID: 29238067 Free PMC article.
-
The MYCN oncogene and differentiation in neuroblastoma.Semin Cancer Biol. 2011 Oct;21(4):256-66. doi: 10.1016/j.semcancer.2011.08.001. Epub 2011 Aug 9. Semin Cancer Biol. 2011. PMID: 21849159 Review.
-
Neuroblastoma models for insights into tumorigenesis and new therapies.Expert Opin Drug Discov. 2015 Jan;10(1):53-62. doi: 10.1517/17460441.2015.974544. Epub 2014 Oct 25. Expert Opin Drug Discov. 2015. PMID: 25345447 Review.
Cited by
-
Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis.PLoS One. 2015 Jul 29;10(7):e0133897. doi: 10.1371/journal.pone.0133897. eCollection 2015. PLoS One. 2015. PMID: 26222553 Free PMC article.
-
WNT Signaling in Neuroblastoma.Cancers (Basel). 2019 Jul 19;11(7):1013. doi: 10.3390/cancers11071013. Cancers (Basel). 2019. PMID: 31331081 Free PMC article. Review.
-
A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.Cancers (Basel). 2021 Nov 3;13(21):5528. doi: 10.3390/cancers13215528. Cancers (Basel). 2021. PMID: 34771690 Free PMC article. Review.
-
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.J Immunol Res. 2018 Jul 11;2018:7394268. doi: 10.1155/2018/7394268. eCollection 2018. J Immunol Res. 2018. PMID: 30116755 Free PMC article. Review.
-
Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.Front Oncol. 2019 Apr 16;9:275. doi: 10.3389/fonc.2019.00275. eCollection 2019. Front Oncol. 2019. PMID: 31058082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases